Biohaven Ltd.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$745.4M | -$885.1M | -$436.1M | -$567.9M | -$218.9M |
| Operating expenses | — | — | — | $567.9M | $218.9M |
| Cash from operations | -$609.4M | -$582.5M | -$331.7M | -$297.7M | -$145.8M |
| Capital expenditure | $715,000 | $4.0M | $3.0M | $6.1M | $938,000 |
| Free cash flow | -$610.2M | -$586.5M | -$334.8M | -$303.8M | -$146.8M |
| Total assets | $451.4M | $615.1M | $513.2M | $661.8M | $142.1M |
| Total liabilities | $399.4M | $191.7M | $85.2M | $123.0M | $47.4M |
Shares outstanding 150.6M · Free float 99.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.